Scotia Capital’s Nu Skin NUS Stock Holding History

Scotia Capital’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,243	Closed	-$198K	–	937
2025 Q3	$198K	Buy	+16,243	New	+$171K	﹤0.01%	852
2014 Q3	–	Sell	-3,440	Closed	-$254K	–	607
2014 Q2	$254K	Buy	+3,440	New	+$271K	0.01%	498

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Scotia Capital's NUS Position: Q4 2025 in Review

Scotia Capital sold out of Nu Skin (NUS) in Q4 2025, closing a stake of 16,243 shares — an estimated $198K sold.

Scotia Capital first reported a position in NUS in Q2 2014 and held it in 2 quarters. The position peaked at $254K in Q2 2014. 187 funds tracked by Wall St. Rank hold NUS as of Q4 2025.

Scotia Capital reported no remaining Nu Skin position as of Q4 2025 after selling out during the quarter.
Scotia Capital sold 16,243 Nu Skin shares in Q4 2025, an estimated $198K.
Scotia Capital first reported a position in Nu Skin in Q2 2014 and held it in 2 quarters.
Scotia Capital's Nu Skin position peaked at $254K in Q2 2014.
187 funds tracked by Wall St. Rank held Nu Skin as of Q4 2025.

Based on Scotia Capital's 13F filing for Q4 2025, filed 12 Feb 2026.